|Last Price||Today's Change||52-Week Range||Trading Volume|
|7.51||0.00 (0.00%)||7.38 - 10.26||45.2 thousand (Below Avg)|
Market data as of 12:00AM 10/01/14. Quotes are delayed by at least 15 min.
These seven metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
|Performed well consistently?||Fail|
|Avoids excess debt?||Fail|
|Converting sales to profits?||Fail|
|Shareholder's money handled rationally?||Neutral|
|Increased shareholder value?||Neutral|
|Consistently increased owner earnings?||Fail|
|Sells at 25% discount to intrinsic value?||Fail|
These eight metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
|Pays a cash dividend?||Fail|
|Room to increase dividends?||Pass|
|Increased earnings over time?||Pass|
|Borrows within reasonable limits?||Fail|
|Stock is undervalued?||Pass|
|Have investors caught on?||Fail|
|Has support of institutional investors?||Fail|
|Has sufficient liquidity?||Pass|
PDL BIOPHARMA SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against PDL BioPharma, Inc.
PR Newswire - Monday 09/29/2014 7:44 PM ET
SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In PDL BioPharma, Inc. To Contact Brower Piven Before The November 17, 2014 Lead Plaintiff Deadline In Class Action Lawsuit
Business Wire - Monday 09/29/2014 5:45 PM ET
Lifshitz & Miller Law Firm Announces Investigation of CommVault Systems, Inc., Dresser-Rand Group Inc., PDL BioPharma, Inc., Santander Consumer USA Holdings Inc., Sigma-Aldrich Corporation, and Viasystems Group, Inc.
PR Newswire - Wednesday 09/24/2014 6:46 PM ET
PDL BioPharma Shareholder Alert: Former SEC Attorney Willie Briscoe and Powers Taylor Investigate Possible Breaches of Fiduciary Duty by Officers and Directors
Business Wire - Wednesday 09/24/2014 12:04 PM ET
PDL BioPharma Responds to Class Action Lawsuit
PR Newswire - Tuesday 09/23/2014 9:00 AM ET
Harwood Feffer LLP Announces Investigation of PDL BioPharma, Inc.
PR Newswire - Friday 09/19/2014 8:10 PM ET
INVESTOR ALERT: Investigation on Behalf of PDL BioPharma, Inc. Shareholders Announced by Glancy Binkow & Goldberg LLP
Business Wire - Friday 09/19/2014 5:51 PM ET
PDL BioPharma Issues Statement on Resignation of Ernst and Young as Corporate Auditors
PR Newswire - Wednesday 09/17/2014 5:57 PM ET
|Revenue Growth (1yr)||13.77%|
|Net Income Growth (1yr)||15.11%|